Matthew Brobeck

1.2k total citations · 1 hit paper
8 papers, 403 citations indexed

About

Matthew Brobeck is a scholar working on Infectious Diseases, Genetics and Surgery. According to data from OpenAlex, Matthew Brobeck has authored 8 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Genetics and 2 papers in Surgery. Recurrent topics in Matthew Brobeck's work include SARS-CoV-2 and COVID-19 Research (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Matthew Brobeck is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Matthew Brobeck collaborates with scholars based in United States and Chile. Matthew Brobeck's co-authors include Fernando Figueroa, Pamela Rojo, Maroun Khoury, Carolina Nazzal, Amit N. Patel, Ricardo Larrea, Fernando Verdugo, Francisca Alcayaga‐Miranda, Paz L. González and Rubén Lamich and has published in prestigious journals such as Blood, Circulation Research and Scientific Reports.

In The Last Decade

Matthew Brobeck

8 papers receiving 396 citations

Hit Papers

Safety and Efficacy of the Intravenous Infusion of Umbili... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Brobeck United States 5 213 199 130 86 34 8 403
Reena Khianey United States 6 211 1.0× 291 1.5× 166 1.3× 108 1.3× 15 0.4× 13 449
Rubén Lamich Chile 5 218 1.0× 253 1.3× 133 1.0× 88 1.0× 9 0.3× 14 434
Ricardo Larrea Chile 4 213 1.0× 206 1.0× 130 1.0× 86 1.0× 5 0.1× 10 369
Claudia Serrano Spain 6 217 1.0× 188 0.9× 123 0.9× 75 0.9× 9 0.3× 9 400
Ema Abarzúa Chile 3 215 1.0× 205 1.0× 127 1.0× 87 1.0× 5 0.1× 3 352
Jorge Bartolucci Chile 6 307 1.4× 277 1.4× 206 1.6× 98 1.1× 6 0.2× 12 519
S Mancini Italy 10 143 0.7× 197 1.0× 89 0.7× 21 0.2× 11 0.3× 17 465
Duc Vu United States 13 105 0.5× 126 0.6× 313 2.4× 51 0.6× 7 0.2× 21 560
Ludovic Couty France 9 134 0.6× 81 0.4× 59 0.5× 32 0.4× 7 0.2× 14 304
T. I. G. van der Spoel Netherlands 12 208 1.0× 324 1.6× 300 2.3× 130 1.5× 25 0.7× 18 669

Countries citing papers authored by Matthew Brobeck

Since Specialization
Citations

This map shows the geographic impact of Matthew Brobeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Brobeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Brobeck more than expected).

Fields of papers citing papers by Matthew Brobeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Brobeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Brobeck. The network helps show where Matthew Brobeck may publish in the future.

Co-authorship network of co-authors of Matthew Brobeck

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Brobeck. A scholar is included among the top collaborators of Matthew Brobeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Brobeck. Matthew Brobeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Berenson, James R., Stephanie R. Rice, Ralph V. Boccia, et al.. (2024). A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone. Targeted Oncology. 19(3). 343–357. 2 indexed citations
2.
Berenson, James R., Stephanie R. Rice, Ralph V. Boccia, et al.. (2023). A Phase 1 Trial Evaluating the Addition of Lenalidomide to Relapsed/Refractory Multiple Myeloma Patients Progressing on Ruxolitinib and Methylprednisolone. Blood. 142(Supplement 1). 4753–4753. 1 indexed citations
3.
Kojima, Noah, et al.. (2022). Incidence of SARS-CoV-2 infection among previously infected or vaccinated employees. International Journal of Infectious Diseases. 118. 21–23. 7 indexed citations
4.
Kojima, Noah, Matthew Brobeck, Vladimir I. Slepnev, & Jeffrey D. Klausner. (2022). A national survey of early treatment seeking behavior among those with incident SARS-CoV-2 infection. Respiratory Medicine and Research. 82. 100934–100934. 2 indexed citations
5.
Kojima, Noah, Lauren Lopez, Melanie A. MacMullan, et al.. (2021). Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 mRNA vaccination. Scientific Reports. 11(1). 24448–24448. 30 indexed citations
6.
Willick, Stuart E., et al.. (2020). The NICA injury surveillance system: Design, methodology and preliminary data of a prospective, longitudinal study of injuries in youth cross country mountain bike racing. Journal of science and medicine in sport. 24(10). 1032–1037. 9 indexed citations
7.
Cushman, Daniel M., et al.. (2020). Postrace Dry Needling Does Not Reduce Subsequent Soreness and Cramping—A Randomized Controlled Trial. Clinical Journal of Sport Medicine. 31(3). 225–231. 7 indexed citations
8.
Bartolucci, Jorge, Fernando Verdugo, Paz L. González, et al.. (2017). Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure. Circulation Research. 121(10). 1192–1204. 345 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026